These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


349 related items for PubMed ID: 20175222

  • 1. PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans.
    Cervenka S, Varrone A, Fransén E, Halldin C, Farde L.
    Synapse; 2010 Jun; 64(6):478-85. PubMed ID: 20175222
    [Abstract] [Full Text] [Related]

  • 2. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding.
    Cervenka S, Pålhagen SE, Comley RA, Panagiotidis G, Cselényi Z, Matthews JC, Lai RY, Halldin C, Farde L.
    Brain; 2006 Aug; 129(Pt 8):2017-28. PubMed ID: 16816393
    [Abstract] [Full Text] [Related]

  • 3. Striatal and extrastriatal dopamine D2 receptor occupancy by a novel antipsychotic, blonanserin: a PET study with [11C]raclopride and [11C]FLB 457 in schizophrenia.
    Tateno A, Arakawa R, Okumura M, Fukuta H, Honjo K, Ishihara K, Nakamura H, Kumita S, Okubo Y.
    J Clin Psychopharmacol; 2013 Apr; 33(2):162-9. PubMed ID: 23422369
    [Abstract] [Full Text] [Related]

  • 4. Low convergent validity of [11C]raclopride binding in extrastriatal brain regions: A PET study of within-subject correlations with [11C]FLB 457.
    Freiburghaus T, Svensson JE, Matheson GJ, Plavén-Sigray P, Lundberg J, Farde L, Cervenka S.
    Neuroimage; 2021 Feb 01; 226():117523. PubMed ID: 33144221
    [Abstract] [Full Text] [Related]

  • 5. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N, Galineau L, Willeit M, Mizrahi R, Bloomfield PM, Seeman P, Houle S, Kapur S, Wilson AA.
    J Neurochem; 2006 May 01; 97(4):1089-103. PubMed ID: 16606355
    [Abstract] [Full Text] [Related]

  • 6. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.
    Kegeles LS, Slifstein M, Frankle WG, Xu X, Hackett E, Bae SA, Gonzales R, Kim JH, Alvarez B, Gil R, Laruelle M, Abi-Dargham A.
    Neuropsychopharmacology; 2008 Dec 01; 33(13):3111-25. PubMed ID: 18418366
    [Abstract] [Full Text] [Related]

  • 7. Effect of endogenous dopamine on extrastriatal [¹¹C]FLB 457 binding measured by PET.
    Okauchi T, Suhara T, Maeda J, Kawabe K, Obayashi S, Suzuki K.
    Synapse; 2001 Aug 01; 41(2):87-95. PubMed ID: 11400175
    [Abstract] [Full Text] [Related]

  • 8. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
    Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn RN, Searle GE, Vora S, Litschge M, Kendro S, Cooper TB, Mathis CA, Laruelle M.
    Synapse; 2009 Jun 01; 63(6):447-61. PubMed ID: 19217025
    [Abstract] [Full Text] [Related]

  • 9. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
    Agid O, Mamo D, Ginovart N, Vitcu I, Wilson AA, Zipursky RB, Kapur S.
    Neuropsychopharmacology; 2007 Jun 01; 32(6):1209-15. PubMed ID: 17077809
    [Abstract] [Full Text] [Related]

  • 10. Association between striatal and extrastriatal dopamine D2-receptor binding and social desirability.
    Cervenka S, Gustavsson JP, Halldin C, Farde L.
    Neuroimage; 2010 Mar 01; 50(1):323-8. PubMed ID: 20004254
    [Abstract] [Full Text] [Related]

  • 11. Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study.
    Chou YH, Halldin C, Farde L.
    Synapse; 2000 Nov 01; 38(2):138-43. PubMed ID: 11018787
    [Abstract] [Full Text] [Related]

  • 12. Extrastriatal D2 and striatal D2 receptors in depressive illness: pilot PET studies using [11C]FLB 457 and [11C]raclopride.
    Montgomery AJ, Stokes P, Kitamura Y, Grasby PM.
    J Affect Disord; 2007 Aug 01; 101(1-3):113-22. PubMed ID: 17197036
    [Abstract] [Full Text] [Related]

  • 13. No effect of dopamine depletion on the binding of the high-affinity D 2/3 radiotracer [11C]FLB 457 in the human cortex.
    Frankle WG, Mason NS, Rabiner EA, Ridler K, May MA, Asmonga D, Chen CM, Kendro S, Cooper TB, Mathis CA, Narendran R.
    Synapse; 2010 Dec 01; 64(12):879-85. PubMed ID: 20506387
    [Abstract] [Full Text] [Related]

  • 14. Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data.
    Olsson H, Farde L.
    Neuroimage; 2001 Oct 01; 14(4):936-45. PubMed ID: 11554812
    [Abstract] [Full Text] [Related]

  • 15. Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans.
    Riccardi P, Li R, Ansari MS, Zald D, Park S, Dawant B, Anderson S, Doop M, Woodward N, Schoenberg E, Schmidt D, Baldwin R, Kessler R.
    Neuropsychopharmacology; 2006 May 01; 31(5):1016-26. PubMed ID: 16237395
    [Abstract] [Full Text] [Related]

  • 16. Striatal and extrastriatal dopamine D₂ receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [¹¹C]raclopride and [¹¹C]FLB457.
    Takahata K, Ito H, Takano H, Arakawa R, Fujiwara H, Kimura Y, Kodaka F, Sasaki T, Nogami T, Suzuki M, Nagashima T, Shimada H, Kato M, Mimura M, Suhara T.
    Psychopharmacology (Berl); 2012 Jul 01; 222(1):165-72. PubMed ID: 22237854
    [Abstract] [Full Text] [Related]

  • 17. Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride.
    Riccardi P, Baldwin R, Salomon R, Anderson S, Ansari MS, Li R, Dawant B, Bauernfeind A, Schmidt D, Kessler R.
    Biol Psychiatry; 2008 Jan 15; 63(2):241-4. PubMed ID: 17586476
    [Abstract] [Full Text] [Related]

  • 18. Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysis.
    Hietala J, Någren K, Lehikoinen P, Ruotsalainen U, Syvälahti E.
    J Cereb Blood Flow Metab; 1999 Feb 15; 19(2):210-7. PubMed ID: 10027776
    [Abstract] [Full Text] [Related]

  • 19. Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).
    Vernaleken I, Fellows C, Janouschek H, Bröcheler A, Veselinovic T, Landvogt C, Boy C, Buchholz HG, Spreckelmeyer K, Bartenstein P, Cumming P, Hiemke C, Rösch F, Schäfer W, Wong DF, Gründer G.
    J Clin Psychopharmacol; 2008 Dec 15; 28(6):608-17. PubMed ID: 19011428
    [Abstract] [Full Text] [Related]

  • 20. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K, Johansson JJ, Tuokkola T, Någren K, Rinne JO.
    Neuroimage; 2013 Nov 15; 82():252-9. PubMed ID: 23727314
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.